Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2025-12-25 @ 1:06 PM
NCT ID:
NCT02978859
Group ID:
EG000
Title:
MGCD516
Description:
Patients with locally advanced and unresectable or metastatic sarcoma will receive MGCD516 at the discretion of the principal investigator until disease progression, unacceptable toxicity or adverse event(s) or withdrawal of consent.
MGCD516: Administered at 150 mg orally, daily, in continuous 21 day cycles. An orally available, potent small molecular inhibitor of several related receptor tyrosine kinases.
Deaths Number Affected:
21
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
29
Other Number Affected:
17
Other Number At Risk:
29
Study:
NCT02978859
Results Section:
NCT02978859
Adverse Events Module:
NCT02978859